3.1462
Anteris Technologies Global Corp stock is traded at $3.1462, with a volume of 43,546.
It is up +5.16% in the last 24 hours and down -22.36% over the past month.
Anteris Technologies Global Corp is a structural heart company committed to designing, developing, and commercializing cutting-edge medical devices to restore healthy heart function. Its product, the DurAVR Transcatheter Heart Valve (THV), was designed in partnership with the world's interventional cardiologists and cardiac surgeons to treat aortic stenosis a potentially life-threatening condition resulting from the narrowing of the aortic valve. The balloon-expandable DurAVR THV is the first biomimetic valve, which is shaped to mimic the performance of a healthy human aortic valve and aims to replicate normal aortic blood flow. Company operates in USA, Germany, Australia, Switzerland, and Sweden. Majority of revenue is from USA.
See More
Previous Close:
$3.005
Open:
$2.98
24h Volume:
43,546
Relative Volume:
0.19
Market Cap:
$113.42M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-1.5903
EPS:
-1.9784
Net Cash Flow:
-
1W Performance:
+8.97%
1M Performance:
-22.36%
6M Performance:
-47.25%
1Y Performance:
+0.00%
Anteris Technologies Global Corp Stock (AVR) Company Profile
Name
Anteris Technologies Global Corp
Sector
Industry
Phone
651-493-0606
Address
860 BLUE GENTIAN ROAD, EAGAN
Compare AVR with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
AVR
Anteris Technologies Global Corp
|
3.145 | 114.50M | 0 | 0 | 0 | -1.9784 |
![]()
ISRG
Intuitive Surgical Inc
|
511.80 | 185.10B | 8.71B | 2.48B | 1.75B | 6.82 |
![]()
BDX
Becton Dickinson Co
|
180.39 | 50.76B | 20.87B | 1.50B | 2.59B | 5.24 |
![]()
ALC
Alcon Inc
|
88.04 | 43.19B | 9.93B | 1.12B | 1.58B | 2.25 |
![]()
RMD
Resmed Inc
|
266.31 | 37.26B | 5.02B | 1.31B | 1.56B | 8.91 |
![]()
WST
West Pharmaceutical Services Inc
|
216.62 | 16.13B | 2.90B | 467.20M | 306.90M | 6.37 |
Anteris Technologies Global Corp Stock (AVR) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Jan-08-25 | Initiated | Lake Street | Buy |
Jan-07-25 | Initiated | Barclays | Overweight |
Jan-07-25 | Initiated | Cantor Fitzgerald | Overweight |
Jan-07-25 | Initiated | TD Cowen | Buy |
Anteris Technologies Global Corp Stock (AVR) Latest News
What analysts say about Anteris Technologies Global Corp. stockHigh-velocity capital appreciation - Autocar Professional
What drives Anteris Technologies Global Corp. stock priceFree Stock Market Mentorship - PrintWeekIndia
Is Anteris Technologies Global Corp. a good long term investmentExplosive wealth accumulation - jammulinksnews.com
Anteris Technologies Global Corp. Stock Analysis and ForecastFree Predictions - jammulinksnews.com
How Anteris Technologies Global Corp. stock reacts to Fed policy changesSmart Growth Low Risk Picks - Newser
Why Anteris Technologies Global Corp. stock attracts strong analyst attentionFree Stock Market Courses - Newser
What makes Anteris Technologies Global Corp. stock price move sharplyPro Trader Stock Focus - Newser
Anteris Technologies Global (ASX:AVR) Will Have To Spend Its Cash Wisely - Yahoo Finance
Anteris Technologies Announces Cessation of Securities - TipRanks
Anteris Technologies Updates CDI Issuance for June 2025 - TipRanks
Anteris Technologies Global (ASX:AVR shareholders incur further losses as stock declines 15% this week, taking three-year losses to 72% - simplywall.st
Anteris Technologies Global (ASX:AVR) investors are sitting on a loss of 66% if they invested three years ago - Yahoo
FY2026 Earnings Forecast for AVR Issued By Cantor Fitzgerald - Defense World
Anteris Technologies Strengthens Board with Key Appointments - MSN
Anteris appoints David Roberts, Gregory Moss to its Board - Medical Buyer
Anteris Technologies Announces Director Departure - TipRanks
Anteris Appoints David Roberts and Gregory Moss to its Board of Directors - The Manila Times
Anteris Appoints David Roberts and Gregory Moss to its Board of Directors - GlobeNewswire Inc.
Kalkine: Leadership Reshuffle at Anteris (ASX:AVR) Highlights Strategic Growth Amid ASX200 Momentum - Kalkine Media
anteris technologies appoints new board members and announces resignation By Investing.com - Investing.com South Africa
Anteris Technologies Appoints New Board Members - TipRanks
anteris technologies appoints new board members and announces resignation - Investing.com
Anteris Technologies Expands CDI Issuance in Strategic Securities Adjustment - TipRanks
Analyzing MSA Safety (NYSE:MSA) & Anteris Technologies Global (NASDAQ:AVR) - Defense World
Anteris Technologies Global Corp’s Lock-Up Period Set To End on June 11th (NASDAQ:AVR) - Defense World
Millennium Management LLC Purchases Shares of 313,298 Anteris Technologies Global Corp (NASDAQ:AVR) - Defense World
Will Anteris' DurAVR Spark A Paradigm Shift In The Transcatheter Aortic Valve Replacement Landscape? - RTTNews
Citadel Advisors LLC Makes New Investment in Anteris Technologies Global Corp (NASDAQ:AVR) - Defense World
Critical Survey: Anteris Technologies Global (NASDAQ:AVR) and Vicarious Surgical (NYSE:RBOT) - Defense World
Anteris Technologies advances toward PARADIGM trial after key regulatory and clinical milestones - Proactive financial news
Anteris Technologies Issues New Employee Incentive Securities - TipRanks
Anteris scales for pivotal PARADIGM Trial, plunging R&D investment into clinical activities - Proactive financial news
The morning catch up: ASX to extend gains as global optimism lifts markets - Proactive financial news
Anteris Technologies Global Corp Stock (AVR) Financials Data
Revenue
Net Income
Cash Flow
EPS
Anteris Technologies Global Corp Stock (AVR) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
Paterson Wayne | Chief Executive Officer |
Mar 05 '25 |
Option Exercise |
7.13 |
233,000 |
1,661,290 |
233,000 |
Denaro Stephen | Director |
Mar 11 '25 |
Option Exercise |
7.13 |
16,500 |
117,645 |
23,722 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):